Physicians and scientists with the Epidemiology and Genetics of Lung Cancer Research Program at Mayo Clinic are studying factors that may cause an increased risk of lung cancer and that may impact treatment responses and quality of life.
The best way to study these issues is by gathering information from patients who have received care at Mayo Clinic.
Tobacco use is known to be a leading cause of lung cancer. But not all people who use tobacco develop lung cancer, and not all people with lung cancer have a history of tobacco use.
Some evidence shows that certain people may be at a higher risk of developing lung cancer based on inherited factors passed on from one generation to the next.
The research team in the Epidemiology and Genetics of Lung Cancer Research Program hopes to identify these factors to help prevent future generations from developing lung cancer or other types of cancers.
Participating in lung cancer research
If you meet the research criteria and agree to participate in the lung cancer program, a study assistant schedules an interview or mails a questionnaire to you. The interview takes about 45 minutes. The questionnaire takes about 15 to 30 minutes to complete.
Information about your disease, treatment and health status is required annually starting soon after diagnosis. All information you provide is kept confidential.
Your participation is extremely valuable to these studies. However, participation is voluntary, and medical care at Mayo Clinic is not affected by your decision to participate or not participate in this study on the epidemiology and genetics of lung cancer.
For more information about the lung cancer study at Mayo Clinic, contact the program research team.